Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: Prerequisites for a European 123I-FP-CIT SPECT database

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 1, 2012, Pages 188-197

  Dickson, John Caddell ^a,r   Tossici Bolt, Livia ^b   Sera, Terez ^c   De Nijs, Robin ^d   Booij, Jan ^e   Bagnara, Maria Claudia ^f   Seese, Anita ^g   Koulibaly, Pierre Malick ^h   Akdemir, Umit Ozgur ⁱ   Jonsson, Cathrine ^j   Koole, Michel ^k   Raith, Maria ^l   Lonsdale, Markus Nowak ^m   George, Jean ⁿ   Zito, Felicia ^o   Tatsch, Klaus ^p,q  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SZEGED   (Hungary)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY OF GENOA   (Italy)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h UNIVERSITY HOSPITAL OF NICE   (France)

ⁱ GAZI UNIVERSITY   (Turkey)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k UNIVERSITY OF LEUVEN   (Belgium)

^l MEDICAL UNIVERSITY OF VIENNA   (Austria)

^m BISPEBJERG HOSPITAL   (Denmark)

ⁿ UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^o FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^p Municipal Hospital of Karlsruhe Inc   (Germany)

^q UNIVERSITY OF MUNICH   (Germany)

^r UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

more..

Author keywords

123I FP CIT; Dopamine transporter; Multi centre trials; Normal database; SPECT

Indexed keywords

IODINE 123; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; DIAGNOSTIC AGENT; TROPANE DERIVATIVE;

ARTICLE; BRAIN SCINTISCANNING; CLINICAL PROTOCOL; EVALUATION; HUMAN; IMAGE QUALITY; MULTICENTER STUDY; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CLINICAL TRIAL (TOPIC); EUROPE; FACTUAL DATABASE; MULTICENTER STUDY (TOPIC); NUCLEAR MEDICINE; PRACTICE GUIDELINE; QUALITY CONTROL; STANDARD;

CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; EUROPE; HUMANS; MULTICENTER STUDIES AS TOPIC; NUCLEAR MEDICINE; QUALITY CONTROL; REFERENCE STANDARDS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 84858720482     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1884-z     Document Type: Article

References (24)

1. Geworski L, Knoop BO, de Wit M, Ivancević V, Bares R, Munz DL. Multicenter comparison of calibration and cross calibration of PET scanners. J Nucl Med 2002;43(5):635-9. (Pubitemid 34507115)
2. McEwan AS, Graham MM, Conti PS. Site qualification in multicenter clinical trials. J Nucl Med 2009;50(8):30N.
3. Westerterp M, Pruim J, Oyen W, Hoekstra O, Paans A, Visser E, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging 2007;34(3):392-404. (Pubitemid 46295349)
4. Scheuermann JS, Saffer JR, Karp JS, Levering AM, Siegel BA. Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience. J Nucl Med 2009;50(7):1187-93.
5. Boellaard R, Oyen WJG, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 2008;35(12):2320-33.
6. Graham MM. The Clinical Trials Network of the Society of Nuclear Medicine. Semin Nucl Med 2010;40(5):327-31.
7. McEwan AS, Graham MM, Conti PS. SNM molecular imaging summit introduces clinical trials network. J Nucl Med 2009;50 (4):18N.
8. Kadrmas DJ, Casey ME, Conti M, Jakoby BW, Lois C, Townsend DW. Impact of time-of-flight on PET tumor detection. J Nucl Med 2009;50(8):1315-23.
9. Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62 (2):133-40.
10. McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007;6(4):305-13. (Pubitemid 46367938)
11. Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15 (3):503-10. (Pubitemid 30333223)
12. Schneider SA, Edwards MJ, Mir P, Cordivari C, Hooker J, Dickson J, et al. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007;22(15):2210-5.
13. NEMA. NEMA NU 1: Performance measurements of gamma cameras [Internet]. 2007. Available via http://www.nema.org/stds/nu1.cfm.
14. IAEA. Chapter 8: SPECT systems. In: Quality control of nuclear medicine instrumentation. Vienna: IAEA; 1991. p. 253-300.
15. Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging 2010;37(2):443-50.
16. Tossici-Bolt L, Dickson JC, Sera T, de Nijs R, Bagnara M, Jonsson C, et al. Calibration of gamma camera systems for a multicentre European (123)I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging 2011;38(8):1529-40.
17. Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005;46(7):1109-18. (Pubitemid 43741072)
18. Christian PE. Ensuring standardization and harmonization in multicenter clinical trials. J Nucl Med 2009;50(5):20N.
19. Koch W, Radau PE, Münzing W, Tatsch K. Cross-camera comparison of SPECT measurements of a 3-D anthropomorphic basal ganglia phantom. Eur J Nucl Med Mol Imaging 2006;33 (4):495-502.
20. Geworski L, Knoop BO, de Cabrejas ML, Knapp WH, Munz DL. Recovery correction for quantitation in emission tomography: a feasibility study. Eur J Nucl Med 2000;27(2):161-9.
21. Soret M, Koulibaly PM, Darcourt J, Hapdey S, Buvat I. Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT. J Nucl Med 2003;44(7):1184-93.
22. Soret M, Koulibaly PM, Darcourt J, Buvat I. Partial volume effect correction in SPECT for striatal uptake measurements in patients with neurodegenerative diseases: impact upon patient classification. Eur J Nucl Med Mol Imaging 2006;33(9):1062-72. (Pubitemid 44215672)
23. Hutton BF, Lau YH. Application of distance-dependent resolution compensation and post-reconstruction filtering for myocardial SPECT. Phys Med Biol 1998;43(6):1679-93. (Pubitemid 28277302)
24. Teo B, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, et al. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med 2007;48(5):802-10. (Pubitemid 47604982)